The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 55 (3) , 317-324
- https://doi.org/10.1016/s0167-8140(00)00138-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Lung Cancer, 1998
- Predicting radiation responseInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Physical and biological predictors of changes in whole-lung function following thoracic irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Dose escalation for non-small cell lung cancer using conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1997
- The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Mediastinal staging of non-small-cell lung cancer with positron emission tomography.American Journal of Respiratory and Critical Care Medicine, 1995
- Thoracic Nodal Staging With PET Imaging With 18FDG in Patients With Bronchogenic CarcinomaChest, 1995
- Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Predictive value of laboratory testsThe American Journal of Cardiology, 1975